المؤلفون: Bedogni Alberto, Mauceri Rodolfo, Fusco Vittorio, Bertoldo Francesco, Bettini Giordana, Di, Fede Olga, Lo, Casto Antonio, Marchetti Claudio, Panzarella Vera, Saia Giorgia, Vescovi Paolo, Campisi Giuseppina

المساهمون: Bedogni, Alberto, Mauceri, Rodolfo, Fusco, Vittorio, Bertoldo, Francesco, Bettini, Giordana, Di , Fede, Olga, Lo , Casto, Antonio, Marchetti, Claudio, Panzarella, Vera, Saia, Giorgia, Vescovi, Paolo, Campisi, Giuseppina

مصطلحات موضوعية: bisphosphonate, bone density conservation agent, Denosumab, MRONJ, ONJ, osteonecrosis of the jaw

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38317291; info:eu-repo/semantics/altIdentifier/wos/WOS:001158010200001; firstpage:1; lastpage:31; numberofpages:31; journal:ORAL DISEASES; https://hdl.handle.net/11577/3509943Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85184738409

الإتاحة: https://doi.org/10.1111/odi.14887Test
https://hdl.handle.net/11577/3509943Test

المؤلفون: Anastasilakis, Athanasios D, Pepe, Jessica, Napoli, Nicola, Palermo, Andrea, Magopoulos, Christos, Khan, Aliya A, Zillikens, M Carola, Body, Jean-Jacques

المساهمون: Anastasilakis, Athanasios D, Pepe, Jessica, Napoli, Nicola, Palermo, Andrea, Magopoulos, Christo, Khan, Aliya A, Zillikens, M Carola, Body, Jean-Jacques

مصطلحات موضوعية: bisphosphonate, bone metastase, denosumab, osteonecrosis of the jaw, osteoporosi, diphosphonate, human, jaw, syndrome, bisphosphonate-associated osteonecrosis of the jaw, bone density conservation agent, bone neoplasms

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34922381; info:eu-repo/semantics/altIdentifier/wos/WOS:000756813900001; volume:107; issue:5; firstpage:1441; lastpage:1460; numberofpages:20; journal:THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM; http://hdl.handle.net/11573/1650841Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85125749898

الإتاحة: https://doi.org/10.1210/clinem/dgab888Test
http://hdl.handle.net/11573/1650841Test

المؤلفون: Campisi G., Mauceri R., Bertoldo F., Bettini G., Biasotto M., Colella G., Consolo U., Di Fede O., Favia G., Fusco V., Gabriele M., Lo Casto A., Lo Muzio L., Marcianò A., Mascitti M., Meleti M., Mignogna M. D., Oteri G., Panzarella V., Romeo U., Santarelli A., Vescovi P., Marchetti C., Bedogni A.

المساهمون: Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., Fusco, V., Gabriele, M., Lo Casto, A., Lo Muzio, L., Marcianò, A., Mascitti, M., Meleti, M., Mignogna, M. D., Oteri, G., Panzarella, V., Romeo, U., Santarelli, A., Vescovi, P., Marchetti, C., Bedogni, A.

مصطلحات موضوعية: antiangiogenic agent, antiresorptive drug, bisphosphonate, cancer, denosumab, dentistry, MRONJ, oral surgery, osteoporosi, prevention model, bisphosphonate-associated osteonecrosis of the jaw, bone density conservation agent, diphosphonate, human, Italy, quality of life

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32824826; info:eu-repo/semantics/altIdentifier/wos/WOS:000565084100001; Symposium of the Italian Society of Oral Pathology and Medicine (SIPMO); volume:17; issue:16; firstpage:1; lastpage:15; numberofpages:15; journal:INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH; http://hdl.handle.net/11573/1562955Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85089496561

الإتاحة: https://doi.org/10.3390/ijerph17165998Test
http://hdl.handle.net/11573/1562955Test

المؤلفون: Lo Faro, Alfredo Fabrizio, Giorgetti, Raffaele, Busardò, Francesco Paolo, Lodi, Giovanni, Martini, Valeria, Pispero, Alberto, Iriti, Marcello, Varoni, Elena Maria

المساهمون: A.F. Lo Faro, R. Giorgetti, F.P. Busardò, G. Lodi, V. Martini, A. Pispero, M. Iriti, E.M. Varoni

مصطلحات موضوعية: Bisphosphonate, Liquid chromatography, Mass spectrometry, Osteonecrosi, Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agent, Chromatography, High Pressure Liquid, Female, Human, Jaw, Male, Middle Aged, Reproducibility of Result, Zoledronic Acid, Spectrometry, Mass, Electrospray Ionization, Tandem Mass Spectrometry, Analytical Chemistry, Drug Discovery3003 Pharmaceutical Science, Spectroscopy, Clinical Biochemistry, Settore MED/28 - Malattie Odontostomatologiche, Settore MED/43 - Medicina Legale

الوقت: 3003

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30273818; info:eu-repo/semantics/altIdentifier/wos/WOS:000449244100034; volume:162; firstpage:286; lastpage:290; numberofpages:5; journal:JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS; http://hdl.handle.net/2434/707742Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85054034264

الإتاحة: https://doi.org/10.1016/j.jpba.2018.09.042Test
http://hdl.handle.net/2434/707742Test

المؤلفون: Mazziotti, Gherardo, Pedersini, Rebecca, Vena, Walter, Cosentini, Deborah, Carrone, Flaminia, Pigni, Stella, Simoncini, Edda L, Torrisi, Rosalba, Zambelli, Alberto, Farina, Davide, Balzarini, Luca, Lania, Andrea G, Berruti, Alfredo

المساهمون: Mazziotti, Gherardo, Pedersini, Rebecca, Vena, Walter, Cosentini, Deborah, Carrone, Flaminia, Pigni, Stella, Simoncini, Edda L, Torrisi, Rosalba, Zambelli, Alberto, Farina, Davide, Balzarini, Luca, Lania, Andrea G, Berruti, Alfredo

مصطلحات موضوعية: Aromatase inhibitor, Bisphosphonate, Bone mineral density, Denosumab, Osteoporosi, Vertebral fracture, Bone Density, Child, Preschool, Diphosphonate, Female, Human, Prospective Studie, Zoledronic Acid, Bone Density Conservation Agent, Breast Neoplasm, Fractures, Bone, Spinal Fractures

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35902384; info:eu-repo/semantics/altIdentifier/wos/WOS:000832486100001; volume:111; issue:5; firstpage:466; lastpage:474; numberofpages:9; journal:CALCIFIED TISSUE INTERNATIONAL; http://hdl.handle.net/11379/564185Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85136866350

الإتاحة: https://doi.org/10.1007/s00223-022-01011-wTest
http://hdl.handle.net/11379/564185Test

المؤلفون: Tempesta A., Capodiferro S., Mauceri R., Lauritano D., Maiorano E., Favia G., Limongelli L.

المساهمون: Tempesta, A., Capodiferro, S., Mauceri, R., Lauritano, D., Maiorano, E., Favia, G., Limongelli, L.

مصطلحات موضوعية: antiangiogenic drug, antiresorptive drug, bisphosphonate, medication-related osteonecrosis of the jaw, peri-implantiti, Dental Care, Diphosphonate, Human, Wound Healing, Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agent, Peri-Implantitis

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33844402; info:eu-repo/semantics/altIdentifier/wos/WOS:000646729400001; volume:28; issue:6; firstpage:1603; lastpage:1609; journal:ORAL DISEASES; http://hdl.handle.net/11586/393597Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104408738

الإتاحة: https://doi.org/10.1111/odi.13873Test
http://hdl.handle.net/11586/393597Test

المؤلفون: KoçyiÄŸit H., Akarirmak Ãœ., Eskiyurt N., Esmaeilzadeh S., Kuru O., Yalçinkaya E.Y., Peker O.

مصطلحات موضوعية: Compliance, clinical trial, Bisphosphonate, Dosing regimen, Osteoporosis, Persistence, Training, bisphosphonic acid derivative, bone density conservation agent, aged, controlled study, drug administration, female, human, medication compliance, middle aged, multicenter study, Postmenopausal, patient education, procedures, prospective study, randomized controlled trial, statistics and numerical data, Turkey, Bone Density Conservation Agents, Diphosphonates, Drug Administration Schedule, Humans, Medication Adherence, Patient Education as Topic

العلاقة: Acta Orthopaedica et Traumatologica Turcica; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11499/47672Test; https://doi.org/10.1590/S0080-623420160000500008Test; 50; 592; 599; 2-s2.0-84994106436

الإتاحة: https://doi.org/10.1590/S0080-623420160000500008Test
https://hdl.handle.net/11499/47672Test

المؤلفون: Akarırmak, Ülkü, Kocyiğit, Hikmet, Eskiyurt, Nurten, Esmaeilzadeh, Sina, Kuru, Ömer, Yalcınkaya, Ebru Yılmaz, Peker, Özlen, Ekim, Ayşe Aydemir, Özgirgin, Neşe, Çalış, Mustafa, Rezvani, Aylin, Çevikol, Alev, Eyigör, Sibel, Şendur, Ömer Faruk

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı., İrdesel, Jale Fatma, 56631533300

مصطلحات موضوعية: Orthopedics, Osteoporosis, Bisphosphonate, Training, Dosing regimen, Compliance, Persistence, Medications, Adherence, France, Impact, Women, Denosumab, Bisphosphonic Acid Derivative, Bone Density Conservation Agent

وصف الملف: application/pdf

العلاقة: Makale - Uluslararası Hakemli Dergi; Acta Orthopaedica et Traumatologica Turcica; Yurt içi; Sanayi; Akarırmak, Ü. vd. (2016). "Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis". Acta Orthopaedica et Traumatologica Turcica, 50(4), 415-423.; https://doi.org/10.1016/j.aott.2016.07.001Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197458Test/; http://hdl.handle.net/11452/31427Test; 000384750400006; 2-s2.0-85012026170; 415; 423; 50

الإتاحة: https://doi.org/10.1016/j.aott.2016.07.001Test
http://hdl.handle.net/11452/31427Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197458Test/

المؤلفون: Antonio Russo, Francesca Toia, Sergio Rizzo, Giuseppe Badalamenti, Viviana Bazan, Francesco Pantano, Giuseppe Tonini, Daniele Santini, L. Castellana, Antonio Galvano, Lorena Incorvaia, Bruno Vincenzi, Fiorella Guadagni, Giovanna Giuliana

المساهمون: Santini D., Galvano A., Pantano F., Incorvaia L., Rizzo S., Vincenzi B., Castellana L., Giuliana G., Guadagni F., Toia F., Tonini G., Russo A., Badalamenti G., Bazan V.

مصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_specialty, Meta-Analysi, Bone Density Conservation Agent, medicine.medical_treatment, Bone Neoplasms, Breast Neoplasms, Bone Neoplasm, Zoledronic Acid, law.invention, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Humans, Hypocalcaemia, Breast, Adverse effect, Bone Density Conservation Agents, Solid tumor, business.industry, Mortality rate, Prostate, Prostatic Neoplasms, AE, Hematology, Bisphosphonate, SMR, medicine.disease, Bone metastase, 030104 developmental biology, Zoledronic acid, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Meta-analysis, Prostatic Neoplasm, Female, business, Breast Neoplasm, medicine.drug, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe4b1ee9f8a60e3367e930d0e3670ffTest
http://hdl.handle.net/10447/407081Test

المؤلفون: Baio, Gianluca, Barbagallo, Mario, D'Avola, Giovanni, Di Luccio, Andrea, Di Tanna, Gian Luca, Falaschi, Paolo, Iolascon, Giovanni, Malavolta, Nazzarena, Robbiati, Federico, Ulivieri, Fabio Massimo

المساهمون: Baio, Gianluca, Barbagallo, Mario, D'Avola, Giovanni, Di Luccio, Andrea, Di Tanna, Gian Luca, Falaschi, Paolo, Iolascon, Giovanni, Malavolta, Nazzarena, Robbiati, Federico, Ulivieri, Fabio Massimo

مصطلحات موضوعية: Adherence, Bisphosphonate, Bone density, Medication possession ratio, Osteoporosi, Treatment algorithm, Algorithm, Bone Density Conservation Agent, Clinical Protocol, Cost of Illne, Female, Human, Osteoporosis, Postmenopausal, Treatment Outcome, Medication Adherence, Pharmacology, Pharmacology (medical)

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/21226636; info:eu-repo/semantics/altIdentifier/wos/WOS:000286826900007; volume:12; issue:2; firstpage:257; lastpage:268; numberofpages:12; journal:EXPERT OPINION ON PHARMACOTHERAPY; http://hdl.handle.net/10447/297488Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-78651467821

الإتاحة: https://doi.org/10.1517/14656566.2011.537259Test
http://hdl.handle.net/10447/297488Test